That hnRNPA1 expression provided additional prognostic information in patients with Gleason score 4 + 3 cancers, but not in any patient subsets with an identical quantitative Gleason score, demonstrates the power of the quantitative Gleason scoring approach. The gene discussed is HNRNPA1; the disease is cancer.